ZYUS Life Sciences Inc is a biopharmaceutical company based in Saskatoon, Canada, that specializes in the development and distribution of cannabinoid-based therapeutics and phyto-therapeutic compounds. Founded in 2018, the company aims to provide patients with innovative medical solutions to alleviate discomfort associated with chronic diseases, treatment side effects, and age-related conditions. ZYUS promotes cannabinoids as a viable medical option, focusing on the overall well-being of patients rather than solely treating physical ailments. As a licensed producer, ZYUS not only manufactures medical cannabis but also facilitates its distribution for both medical and adult recreational use in Canada, positioning itself as a leader in the adoption of phytotherapeutics in clinical practice.
Phoenix Canada Oil Company Limited, established in 1944 and based in Toronto, Canada, specializes in the exploration and development of oil and natural gas properties, primarily in Western Canada. The company manages a portfolio of investments and holds minority interests in mature gas fields. In recent years, Phoenix has shifted its focus towards developing clean energy solutions, particularly in water-derived hydrogen technologies. Through its subsidiary, Phoenix International Energy, Inc., the company possesses worldwide development rights to a patented hydrogen gas generation technology and is collaborating with academic institutions in Canada to advance this technology to commercial viability. Additionally, Phoenix is involved in research and development efforts with universities and government bodies to create synthetic hydrocarbon fuels derived from water-based hydrogen, leveraging C1 chemistry.
Revon Systems is a developer of a platform for connecting physicians and patients. It offers a web platform that allows physicians to deliver care to patients remotely, specializes in helping patients with cardiovascular and lung conditions to self-manage signs and symptoms, intervene early on health decline that enables patients to manage their health and improve quality of life.
Ehave - Platform
Acquisition in 2019
Ehave - Platform contains components specifically designed to be used by medical cannabis patients to efficiently gather and verify patient-reported outcomes and experiences, evaluate treatment progress, enhance patient engagement and improve data modeling.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.